On May 18, Redica Systems hosted a virtual panel discussion featuring two of our Industry Experts, Senior GMP Quality Expert Jerry Chapman and Senior GMP Expert Barbara W. Unger. Pharmatech Associates, Inc. Executive Director of Regulatory Compliance Stephanie Gaulding was also a featured panelist.

Redica Systems Senior GXP Specialist Jason Kerr moderated the panel.

The following is a select Q&A exploring the technology side of remote audits and virtual GMP inspections. Part I looked at the current state of remote inspections and audits.

[Related: To download the full recording of the panel discussion, click here.]

Remote Panel Discussion

FDA Guidance on Remote Inspections

Jason Kerr

Jason Kerr: The FDA recently published an FDA guidance, Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities During the COVID-19 Public Health Emergency for Industry. Any takeaways or insights from this? Are there any other signals that you found from the guidance that gives you pause and think, ‘I wonder what this will mean in the reality of things in the future?’

Stephanie Gaulding

Stephanie Gaulding: It was reassuring for me because it confirms the experience that I have had working with clients who have undergone virtual inspections in terms of the fact it outlines initial contact and logistics discussion before actually diving into the inspection itself. That mirrored what I had seen in situations where the FDA had done some virtual inspections. It jived with everything that I was expecting, and it was nice to see some of the details around their preferred platform choices.

For instance, Jerry mentioned Health Canada is looking for some very specific video conferencing technology. Having that information upfront enables firms to better prepare for hosting those types of inspections. If they need to invest in a different type of video conferencing technology, they can source that and not have to do it in kind of more of a reactionary mode. But I think specific to the FDA’s document, it was pretty clear to me in terms of what that pattern would be. And I have actually worked with several of my clients to go back and update their internal inspection readiness practices to accommodate for that decision.

Barbara Unger

Barbara W. Unger: I think the same thing. My clients have not had health authority inspections that have been remote, so I cannot speak to how they went through that and how that worked. But I think there were not a lot of surprises in the guidance. It all seemed very consistent with what they have been saying and writing and presenting all along with their approach. But staying away from the phrase ‘remote audit’ in the FDA guidance, I think is definitely striking.

Live vs. Prerecorded Facility Walkthroughs

Jason Kerr: What are your thoughts on prerecorded walkthroughs of processes? Do you have a preference for one or another? Do you have more questions when you see a prerecorded one with no one there versus a live recording with no one there or a live recording with lots of commotion going on? Any thoughts and insights on that?

Stephanie Gaulding: As an auditor, I have to say that there is always a level of question in my head when I look at prerecorded videos of whether it’s operations, facility tours, etc. Are they really showing me everything? I cannot necessarily direct somebody, ‘can you turn around to the left a little bit so I can see what is over there?’ which the live video feed provides. But certainly, if you do encounter a prerecorded video technology of operations, et cetera, there are still a lot of questions that you could answer.

Early in the pandemic I actually had an onsite audit scheduled, and literally, it got canceled two weeks before I was supposed to get on a plane to travel. They rapidly circled back with an opportunity to try and find a way to do that in a remote capacity. And one of the ways the contract manufacturing organization chose to handle it was to do a recorded video tour. But as I was going through the documents, I realized that the video did not include certain areas of their facility, like the warehouse. First, I requested that they update their tour video. But I just asked, ‘can either somebody take a cell phone on a video call with me there so we can see it? Or can you get some still pictures or something so that I can see what that area looks like and how you segregate materials and some of those types of pieces?’

Barbara W. Unger: I am not a fan of prerecorded. It gives you a good idea of what the facility looks like and maybe what the flaws are, but that is about the extent of it. I think it is a balancing act depending on how many people you have in the area. You can have background noise. You can have equipment noise. That makes it very difficult for the person who is conducting the tour to be able to speak over the noise so you can actually hear. Seeing a small number of people is a good thing; that is comforting for me. But I think you do not want too many people there because you will have too much activity.

Jerry Chapman

Jerry Chapman: On our website, there is an article that we published on what I think was the best practice that I have heard of. And it’s a mixture of both. This was from Thermo Fisher Scientific. What they did was they did a combination of both. They used this Matterport 3D technology, which is commonly used by realtors.

If you are going to look to buy a house, you can take a video tour through the house. Walkthrough the house. That is what they did. That’s prerecorded. And what it does is it orients the inspector before they get there to the facility so they can see what is where and how it is all set up. Then, once they get there live, then they actually have a 360° camera mounted on an IV pole with wheels that they can wheel through. And they use Microsoft HoloLens and a software called Avatour. And they got really high marks from an EMA inspector who went through one of these at their site. He could say, ‘okay, zoom in on that. I want to see that. There’s a logbook open there, zoom in on that. I want to see what that looks like. I want to see if it is dated properly.’ And they were able to do that.

Validation of Electronic Signatures

Jason Kerr: With the increased use of electronic signatures, what is the extent of validation you expect to see at the user sites?

Barbara W. Unger: I think remote versus onsite e-signatures, same requirements, same expectations. Just because somebody is signing from their home office, as opposed to their desk in the facility, I would not expect any different.

Stephanie Gaulding: For many companies, I think they kind of fell into one or two categories, pre-pandemic. Those that already had robust e-signature processes and tools in place to begin with, and could be embedded in a platform, or it could be a separate signing tool, like an Adobe Sign or a DocuSign, or any other number of tools that are out there that they have tested and validated appropriately for those purposes.

We certainly saw a number of organizations, or at least I did, that were maybe completely paper-based that started to adopt e-signatures, but I would agree I do not think the validation expectation changes with deploying an e-signature tool, just because of the situation that we have been through. It would be the same.


[Related: To download the full recording of the panel discussion, click here.]

Remote Panel Discussion

Download the Special Report

What You Will Learn from This Report:

The first countrywide import alert issued by FDA

An inadequate deviation investigation

An inadequate product specifications and a product recall

Process validation issues at a CMO

A different perspective on process validation and the culpability of the quality unit

 

Download the Special Report

CDMO Comparison opt-in

In this summary we identify:

FY2018-FY2020 GMP data for Lonza & Catalent

Top GMP primary citations

Top FDA 483 observations

Redica Systems Enforcement Analytics

Prepare for your next inspection.

Enter your email address and someone will contact you shortly to explore enforcement trends. 

Redica Systems Enforcement Analytics

Prepare for your next inspection.

Enter your email address and someone will contact you shortly to explore observations and trends. 

Redica Systems Enforcement Analytics

Prepare for your next inspection.

Enter your email address and someone will contact you shortly to run your custom report.

Redica Systems Enforcement Analytics

Get help choosing the right CRO.

Enter your email address and someone will contact you shortly to customize your insights.

Redica Systems Enforcement Analytics

Compare two companies of your choice.

Enter your email address and someone will contact you shortly to customize your report.

Download the Special Report

Download your copy of THE FDA INSPECTION LANDSCAPE IN MID-2020 AND A LOOK AT VIRTUAL INSPECTION

In this summary we identify:

  • Trend analysis of FDA inspections through mid-2020
  • Strategies for preparing and hosting virtual inspections
  • New technologies to support remote inspections

Panel Discussion – Remote Audits

Panel Discussion opt in image

Featuring Panelists:
—Barbara W. Unger, Unger Consulting, Inc.
—Jerry Chapman, Redica Systems
—Stephanie Gaulding, Pharmatech Associates

Who Will Benefit?
This session will be valuable to GMP quality, regulatory, compliance, and management personnel in FDA-regulated industries who want to have a conversation on remote audits and get to know what is going on in the industry.

Redica Systems Enforcement Analytics

Monitor compliance at your Clinical Investigator sites.

Enter your email address and someone will contact you shortly to get you started.

Turning Failure into Success

Presented on Tuesday, April 27, 2021 by Steve Greer, Executive Coach, Genesis Assist, and former Quality Leader, Procter and Gamble

What you will learn:

  • How to use the Leadership SOS Model to transform quality culture
  • How to strengthen quality systems to eliminate human error
  • How to generate ideas on how to set your organization up for success for shareholders, FDA, and staff
Redica Systems Enforcement Analytics

Get Full Access to Redica Enforcement Analytics

Enter your email address and someone will contact you shortly to answer all of your questions and get you started.

Quality Management Systems for Small Pharma and Biotech Firms

Webinar: QMS for Small Pharma and Biotech Firms

Presented by Fenton Fong, Founder, Managing Director, & Principal at xCellarate

Get instant access to the webinar video and slides.

What you will learn:

  • Common challenges small pharma firms face when developing a QMS
    Recent enforcement trends involving the Quality Unit
    Impact of the COVID-19 pandemic

Download the Special Report

APAC ad

In this summary we identify:

GMP data from FY2017 to FY2020 for the Asia-Pacific region

Top 3 GMP primary and secondary citations

Top 3 483 observations

Download the Special Report

An Analysis Of MHRA’s Latest Annual GMP Inspection Deficiencies Report

In this summary we identify:

  • Data from 2019 UK MHRA Inspections
  • Trends from 2015, 2016, 2018, and 2019 inspections
  • Conclusions drawn from an analysis of drug inspection data

Experience the Power of Redica Systems

Redica Pro Free

Sign up for your FREE account today and get instant access to:

SEARCH Find the inspection records you want by inspector’s name, company name, site, city, country, etc.

WARNING LETTERS Easily search the largest database of FDA Warning Letters by date, company, FDA office, or subject

SITES Quickly assess inspection records including dates and inspectors across all of your sites

INSPECTIONS Complete list of FDA inspections by date, company, category, and country

Get Complete Access to the Redica Systems Platform

Please submit your email address and one of our team members will contact you shortly to answer all of your questions and get you started with the new Enforcement Analytics platform.

Redica Systems Enforcement Analytics

Prepare for inspections of Clinical Investigator sites.

Enter your email address and someone will contact you shortly to provide more Clinical Investigator data about your sites.

Redica Systems Enforcement Analytics

Compare the enforcement history of your CDMOs.

Enter your email address and someone will contact you shortly to customize your report.

A.I. for Quality and Compliance Teams

August 3 webinar

Presented by Redica Systems Senior GMP Quality Expert Jerry Chapman

What you will learn:

  • A basic understanding of data sources, machine learning, NLP, and A.I. tools
  • Building and applying Expert Models
  • Two case studies, one on sterile manufacturing/503B and one on data integrity
Redica Systems Enforcement Analytics

See how we can help you eliminate yet another spreadsheet.

Enter your email address and someone will contact you shortly. 

Get the scoop on recent data integrity 483 observations!

  • FY 2020 Data Integrity 483 Observations
  • Data Integrity Observations for Human Drugs
  • Observations Falling Under GMP
  •  

Human Factors – Compliance and Applications

June webinar

Presented by Alison Sathe, Founder, Regulatory Mark & Valerie Fenster, Director of Insights and  Human Factors, Kaleidoscope Innovation 

What you will learn:

  • Human factors strategies from simple drug products to complex surgical devices
  • Primary and secondary labeling development and evaluation for usability
  • Human factors activities from product development to post-market
  • International strategies: expectations for human factors in regulatory submissions in international markets

Experience the Power of Redica Systems

Redica Systems Enforcement Analytics

Let us know who you are and we’ll be in touch to answer all of your questions and get you started.

Redica Systems Enforcement Analytics

Keep up with the latest Regulatory Developments on Clinical Trials

Enter your email address and someone will contact you shortly. 

Redica Systems Enforcement Analytics

Save your team valuable time when using External Monitoring.

Enter your email address and someone will contact you shortly. 

Redica Systems Enforcement Analytics

Save time and Resources when using External Monitoring.

Enter your email address and someone will contact you shortly. 

Redica Systems Enforcement Analytics

Get immediate access to the news that matters to your sites.

Enter your email address and someone will contact you shortly. 

Redica Systems Enforcement Analytics

Stay ahead of changing regulations.

Enter your email address and someone will contact you shortly to get the data and analysis you need.

Redica Systems Enforcement Analytics

Compare the inspection history of your CDMO sites.

Enter your email address and someone will contact you shortly to customize your report.

Redica Systems Enforcement Analytics

Upgrade your CDMO monitoring strategy.

Enter your email address and someone will contact you shortly to get the data and analysis you need.

Redica Systems Enforcement Analytics

Upgrade your CDMO management strategy.

Enter your email address and someone will contact you shortly to get the reports and analysis you need.

Experience the Power of Redica Systems

Redica Systems Enforcement Analytics

Sign up for your FREE account today and get instant access to Enforcement Analytics.

Redica Systems Enforcement Analytics

Upgrade your inspection strategy.

Enter your email address and someone will contact you shortly to get the reports and analysis you need.

Redica Systems Enforcement Analytics

Upgrade your inspection strategy.

Enter your email address and someone will contact you shortly to get the reports and analysis you need to prepare for your next inspection.

Experience the Power of Redica Systems

Complete the form and one of our experts will reach out to you to schedule a demo and answer questions about our subscription options.

INDEX INFORMATION  Redica consolidates regulatory data in real-time on the single largest database for quality, safety, and compliance intelligence.

STRENGTHEN DATASETS Redica machine intelligence algorithms identify and triage risk signals to derive meaning from vast amounts of private and public data.

ANALYZE & INTERPRET PATTERNS Redica instantly models the customer-specific regulatory risks, trends, and opportunities that stand to fundamentally change compliance operations.

Redica Systems Enforcement Analytics

Evaluate Your CDMOs

Enter your email address and someone will contact you shortly to customize your report.

Discover the power of the most comprehensive database of 483s in existence.

Our database of over 20,000 483s is retyped and tagged, making it easy to create an Observation Report in seconds.

Eliminate days of work and get your FREE personalized 483 Observation Report.